Curaleaf Holdings, Inc.
TSXCURA has lost 15% over the past month and nearly 10% in the past week alone, making it one of the sharper decliners in a cannabis peer group that is broadly under pressure — the question now is whether the stock is being dragged down by sector sentiment or whether something more specific is at work. The broader cannabis space is moving in lockstep to the downside…
Snapshot as of 6 Aug 2026
CURA has lost 15% over the past month and nearly 10% in the past week alone, making it one of the sharper decliners in a cannabis peer group that is broadly under pressure — the question now is whether the stock is…
CURA headed into its Q1 2026 earnings with short sellers already retreating — and the results gave them little reason to return. The company posted Q1 EPS of $0.09, against a consensus estimate of $(0.06) — a $0.15…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CURA — free to start on ORTEX.
Sign up for free →Open CURA on ORTEX